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Background: Recently, Achromobacter xylosoxidans has been related to chronic lung diseases in patients suffering from cystic ﬁbrosis (CF), but its
involvement has not been elucidated. Some virulence properties of A. xylosoxidans isolated from Brazilian patients with CF were revealed in this
work.
Methods: This study examined the production of a cytotoxic factor of A. xylosoxidans capable of stimulating the secretion of inﬂammatory cyto-
kines (IL-6 and IL-8) from lung mucoepidermoid carcinoma cells (NCI-H292). The cytokines were measured using enzyme-linked immunosorbent
(ELISA) assays. To investigate whether the cytotoxic factors may be endotoxins, they were treated with polymyxin B.
Results: The culture supernatants of all A. xylosoxidans produced a heat stable, active cytotoxin in NCI-H292 cells capable of leading to intracel-
lular vacuoles and subsequent cell contact loss, chromatin condensation, a picnotic nucleus and cell death. There was a higher concentration of
proinﬂammatory cytokines in the NCI-H292 cells after 24 h of incubation, with the fraction greater than 50 kDa from the culture supernatant.
The cytotoxin activity remained even after treatment with polymyxin B, which suggested that the release of IL-6 and IL-8 was not stimulated
by lipopolysaccharide (LPS).
Conclusion: The cytotoxic factor produced by A. xylosoxidans may represent an important virulence factor, which when associated with CF chronic
lung inﬂammation, may cause tissue damage and decline of lung function.
© 2012 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: A. xylosoxidans; Cytotoxin; Endotoxin; Cystic ﬁbrosis; Lung inﬂammation1. Introduction
Cystic fibrosis (CF) is the most common inherited lethal dis-
order of homozygous mutant alleles of the CF gene. The muta-
tion is localised at 7q31.2 and causes severe defects in chloride
ion transport, leading to a characteristically salty sweat, which
is more common among the Caucasian population [1].⁎ Corresponding author at: Department of Genetics, Evolution and Bio-agents,
Universidade Estadual de Campinas, Box: 6109-Cep: 13081-970 Campinas, São
Paulo, Brazil. Tel.: +55 19 35216278; fax: +55 19 35217557.
E-mail addresses: rebecapmantovani@yahoo.com.br (R.P. Mantovani),
tyano@unicamp.br (T. Yano).
1569-1993/$ -see front matter © 2012 European Cystic Fibrosis Society. Published
doi:10.1016/j.jcf.2012.02.002In the lungs, mucociliary clearance is impaired, resulting in
persistent colonisation with intermittent episodes of debilitating
and ultimately fatal infection [2,3]. In particular, the accumula-
tion of proinflammatory cytokines, such as IL-6 and IL-8, re-
sults in lung tissue damage [4].
More than 80% of adult CF patients also present chronic
pulmonary infection with Pseudomonas aeruginosa, a Gram
negative bacterium, that is often responsible for morbidity in
CF cases [5,6]. However, an increasing number of other
Gram-negative microorganisms are capable of causing similar
lung chronic infections, like Burkholderia cepacia [5,6] mainly
due to several virulence factors, such as biofilm formation and
proinflammatory cytokine secretion, which allow the strains to
remain in the lungs [7,8]. Achromobacter xylosoxidans hasby Elsevier B.V. All rights reserved.
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patients similarly to P. aeruginosa [9].
Although A. xylosoxidans is not a common respiratory patho-
gen, it has been isolated from the lungs of CF patients with in-
creased incidence in recent years [10]. This bacterium is an
aerobic, motile, oxidase and catalase positive and nonfermenta-
tive Gram-negative bacillus [11]. The colonisation of this patho-
gen has been associated with the exacerbation of pulmonary
symptoms [4]. Additionally, the lung function of patients infected
with A. xylosoxidans may decrease rapidly compared to the CF
patients without this infection [5].
Increased lymphocyte and neutrophil recruitment results
from increased levels of the proinflammatory cytokines IL-6
and IL-8. The exaggerated inflammatory response in CF pro-
motes lumen obstruction, which causes the destruction of
cells in the airways [4].
The airway epithelial cells, which normally express the cys-
tic fibrosis transmembrane conductance regulator (CFTR) gene,
induce inflammatory responses. Defects in the CFTR gene are
associated with an increased production of proinflammatory
mediators, including IL-6 and IL-8 [4,10]. Studies on epithelial
cells have suggested ways in which defects in CFTR function
may influence the infectious and inflammatory processes in
the lungs [12].
Lipopolysaccharides (LPSs) from many Gram-negative bac-
teria, including A. xylosoxidans, release proinflammatory cyto-
kines, such as IL-6 and IL-8 [13], and polymyxin B is used to
eliminate endotoxic activity [14]. However, toxic bacterial
products other than LPS may contribute to the induction of in-
flammatory responses in certain infections. For instance, exo-
products from B. cepacia were able to stimulate IL-8 release
that was not diminished by polymyxin B [15], suggesting the
involvement of factors other than LPS.
The present study aimed to evaluate the capability of
A. xylosoxidans to produce cytotoxins that stimulate the secre-
tion of inflammatory cytokines (IL-6 and IL-8) in lung mucoe-
pidermoid carcinoma cells (NCI-H292). The results may be
helpful to elucidate the mechanism used by A. xylosoxidans to
develop chronic pulmonary infection in patients with CF.
We studied 1350 samples of sputum and oropharyngeal secre-
tion, from 03/01/2007 to 01/31/2009, that were obtained from 216
patients in our Paediatric CF Reference Centre, UNICAMP—
Brazil. Of the 216 patients, 7.41% presented at least one con-
firmed positive culture of A. xylosoxidans and 3.7% fulfilled the
criteria of three or more positive cultures, which indicates a high
prevalence of these bacteria compared with data from other cen-
tres presented in the literature [16–18].
2. Material and methods
2.1. Microorganisms
2.1.1. Bacterial isolation and identification
Seventeen strains of A. xylosoxidans were isolated from the
sputum and oropharyngeal secretions of 216 cystic fibrosis
(CF) from patients attended at the Paediatric CF Reference
Centre, UNICAMP, São Paulo, Brazil. The LMG® 1863(A. xylosoxidans) was used as previously described by Yabuuchi
and Ohyama 1971 [11], as positive control strain of
A. xylosoxidans. All of the isolates were grown in tryptone
soya broth (TSB) (Difco Laboratories, Detroit, MI) at 37 °C,
100 rpm (Incubator shaker, New Brunswick Scientific, USA)
for 24 h. The strains were previously identified by biochemical
and serial analysis of gender by PCR.
2.1.2. Bacterial culture supernatants
A. xylosoxidans strains were grown in TSB medium by
shaking at 100 rpm (New Brunswick Scientific Co.) at 37 °C
for 24 h. The culture supernatants (CS) were collected by cen-
trifugation at 10,000 rpm for 15 min (Bechman, USA) and
were filtered through 0.22 μm membranes (Millipore, USA).
2.2. Cytotoxicity assay
The Human Lung Mucoepidermoid Carcinoma Cell line
(NCI-H292) was purchased from the European Collection of
Cell Cultures (ECACC) and was maintained in RPMI 1640
(Nutricell, Brazil) supplemented with 10% foetal bovine
serum (Nutricell, Brazil) without antibiotics. The cells were
grown in 96- (2.5×105 cells/ml) or 24- (4×105 cells/ml) well
tissue microplates and were incubated at 37 °C, 5% CO2
(Jouan CO2 Incubator, France) for cytotoxicity or ELISA as-
says, respectively.
Briefly, NCI-H292 cells were incubated with the bacterial
CS and the morphological changes were assessed using an
inverted microscope (Nikon Instruments, Japan) with 6, 12,
18, 24 h until 48 h of inoculation was reached.
To analyse the thermostability of the cytotoxins, the bacterial
CS were heated at 100 °C for 15 min, cooled to room temperature
and assayed for cytotoxicity in NCI-H292 cells. Among all of the
strains of A. xylosoxidans, only strain A31 was selected for the
determination of the approximate molecular mass of the cytotoxic
factor present in the cultured supernatants under different dilu-
tions. The culture supernatant was ultrafiltrated using XM-300
and XM-50 cut off Amicon membranes (Millipore, Michigan,
MI). The fractions retained in the membrane were subsequently
filtered through a 0.22 μm membrane (Millipore, Brazil) prior
to the cytotoxicity assay using NCI-H292 cells. TSB was used
as a negative control.
2.2.1. MTT assay
To detect the cellular reduction of MTT [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] (Sigma,
St. Louis, MO) by the mitochondrial dehydrogenase of viable
cells, NCI-H292 cells were grown in 96-well plates for 24 h
and were treated with 4 μg of fraction N50 kDa for 12, 24, and
48 h and after the medium was removed. Fresh medium contain-
ing MTT solution (0.8 mg MTT/ml) was added to each well and
after was incubated for 3 h at 37 °C, in the dark. Subsequently,
the medium was removed and the formazan solubilized in extract
solution HCl 1 N–isopropanol (1:24 v/v). The plate was shaken
for 10 min and the absorbance was measured in a spectrophotom-
eter (Amershan Bioscience, England) at 550 nm (reference to
700 nm).
A B
C D
Fig. 1. Morphological alterations verified by rounding and detaching of cells on
NCI-292 cells caused by different ultrafiltrated fractions of A. xylosoxidans
(strain A31) supernatant after 48 h and at 400×. A—NCI-H292 cell control;
B—NCI-292 cell treated with ultrafiltrated fraction of 300 kDa–50 kDa
(highlighted in figure cellular alteration); C—NCI-292 cell treated with ultrafil-
trated fraction of less than 50 kDa; and D—cells treated with the supernatant
fraction of greater than 300 kDa.
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2.3.1. Toluidine blue (TB) dye assays
The bacterial culture of strain A31 was applied to coverslip-
grown cells over 6, 12, 18, 24, 40 and 48 h. The coverslips were
subsequently washed with phosphate buffered saline (PBS),
fixed in a 10% (v/v) formaldehyde solution in PBS for 1 h,
washed with distilled water, stained with 0.25% (w/v) toluidine
blue (pH 4.0) and washed once more in distilled water. After air
drying, the coverslips were cleared in xylene, mounted on
slides using Entellan (Merck, Whitehouse Station, NJ) and ob-
served by light microscopy (Zeiss, Germany) [19].
2.3.2. Hematoxylin and eosin (HE) assays
The cells were grown in 24- (4×105 cells/ml) well tissue
microplates and were incubated at 37 °C, 5% CO2 (Jouan
CO2 Incubator, France). Bacterial culture supernatant of strain
A31 was applied to coverslip-grown cells over 24, 40 and
48 h. The coverslips were subsequently washed with PBS,
fixed in a 10% (v/v) formaldehyde solution in PBS for 1 h,
washed with distilled water, stained with hematoxylin
(2–3 min), washed with distilled water again and distained
with 0.3% acid alcohol. After the washing step, the cover
slips were stained by an eosin for 12 s, washed with distilled
water, dehydrated, cleared, mounted on slides and observed
by light microscopy (Zeiss, Germany) [19].
2.4. ELISA assay
After the determination of the molecular size of the cytotoxic
fraction of the supernatant of strain A31, the NCI-H292 cells
were grown on 24-well plates (4×105 cells/ml) at 37 °C for
24 h in 5% CO2 and incubated 1 ml with the supernatant of a
sample that had been treated with polymyxin B or not, and with
fractions N50 kDa and b50 kDa (containing 40–50 μg of pro-
tein) for 24 h. Polymyxin B was used to remove endotoxic activ-
ity. The protocol was adopted from Cooperstock et al. [14].
Briefly, the culture supernatants of strain A31 were heated at
100 °C for 15 min and were incubated at 37 °C for 20 min with
polymyxin B (INLAB®, Brazil) at 0.1, 10, 20 and 40 μg/ml.
The supernatant was subsequently tested for cytotoxicity in
NCI-H292 cells. All of the samples and their respective controls
were tested in triplicate and 40 μg/ml was selected for ELISA.
Prior to the enzyme-linked immunosorbent assay (ELISA),
the supernatants of the cells were removed, filtered using
0.22 μm pore-size membrane and frozen with protease inhibitor
cocktail (Sigma®, Germany). The concentrations of IL-6 and
IL-8 in the supernatants (diluted 1:10) were determined by mea-
suring an ELISA according to the instructions of themanufacturer
(R&D Systems, Minneapolis, MN).
2.5. Statistical analyses
All of the data were expressed as the mean and standard
error of the mean (SEM). A comparison of the release of inter-
leukins from the samples and the negative controls (the TSB
groups) was conducted using Dunnett's test for multiplecomparisons. Differences were considered statistically signifi-
cant if Pb0.05.
3. Results
3.1. Cytotoxicity assay
All of the samples showed cytotoxic activity in the NCI-
H292 cells. Culture supernatant filtrates from all of the isolates
of A. xylosoxidans and LMG 1863 caused cell rounding and de-
tachment of cells that were observed after 48 h of incubation.
Accordingly, it was observed that the cellular cytotoxic activity
was not reduced by heating the bacterial supernatant at 100 °C
for 15 min. However, because strain A31 cytotoxicity on NCI-
H292 cells was observed till 1:4 dilution, which indicated
higher cellular activity, unlike the other strains that were ob-
served till 1:2 dilution, it was chosen to identify the approxi-
mate molecular weight of the cytotoxin. When different
ultrafiltrated fractions of A. xylosoxidans supernatant were in-
oculated on NCI-H292 cells, the cytotoxic activity was ob-
served only in the fraction between 300 kDa and 50 kDa
(Fig. 1).
Our results indicate loss of cell viability over time. The ability
of the mitochondria to reduce MTT to formazan, in relation to
time of incubation with the supernatant fraction N50 kDa is
shown in Fig. 2. The mitochondrial activity of the strain A31
was lower than strain LMG 1863 and on overage 0.6 times smal-
ler than the TSB at all times.
3.2. Morphological alteration by supernatants of A. xylosoxidans
NCI-H292 cells did not present morphological changes be-
fore 24 h (at 6, 12, 18 h intervals of incubation), but present
few morphological changes after 24 h as evidenced by the TB
and HE dye assays, at the beginning of vacuolisation in the cy-
toplasm. Exacerbated cytotoxic effects were observed at 40 h
Fig. 2. Kinetics of viability of mitochondrial NCI-H292 cells treated with superna-
tant fraction N50 kDa of the strains A31 and LMG 1863. Reduction of MTT to for-
mazan was measured in different time intervals. The negative control is represented
by TSB, indicating the highest reduction of MTT by NCI-H292 viable cells.
Fig. 3. Optical micrographs of NCI-H292 lung cells treated with A. xylosoxidans (stra
those on the right with HE. A—control without treatment. B, C and D—cells treated
Legends: n (nucleus), c (cytoplasm) and * (vacuoles).
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decrease of cellular contacts and junctions, the presence of a
pericromatic ring, uniform nuclei and the presence of nuclear
bodies with chromatin condensation, which were observed by
the affinity of TB dye to acidic substances, such as the nucleic
acids [19].Within 48 h of incubation, the number of large vacuoles
increased, indicating a large number of vesicles, the loss of cellu-
lar contacts, chromatin condensation and pyknotic nuclei.
3.3. Induction of interleukins 6 and 8
The cytotoxic fraction (N50 kDa) of the A. xylosoxidans cul-
ture strain A31 stimulated IL-6 and IL-8 production in NCI-
H292 cells, as indicated by ELISA .We aimed to determine
whether the bacterium cytotoxin had endotoxic activity,in A31) supernatant, 1000×. The cells in the left figures are stained with TB and
with culture supernatants of A. xylosoxidans after 24, 40 and 48 h, respectively.
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Fig. 4. Secretion of proinflammatory cytokines, A—IL-6 and B—IL-8 from
NCI-H292 cells following stimulation with culture supernatant (CS), the
N50 kDa fraction of the CS, the b50 kDa fraction of the CS, CS with polymyx-
in B cells, cell controls with and without polymyxin B and cells with TSB (neg-
ative control). Concentrations of cytokines were measured by ELISA and
subjected to analysis of variance (ANOVA), followed by Dunnett's test for mul-
tiple comparisons, the results were expressed as median±SD of two indepen-
dent experiments performed in duplicate. CS, CS with polymyxin B cells and
the N50 kDa fraction of the CS, showed significant difference (*Pb0.05) com-
pared with the negative control. polB=40 μg/ml polymyxin B.
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cellular IL-6- and IL-8-inducing activity; however, the
cytotoxin in the CS of the bacterium was not inactivated by
polymyxin B and did not inhibit the production of the superna-
tant of bacteria to release interleukins.
Secretion of IL-6 following the stimulation with CS showed
a median of 180.62 pg/ml, which was almost 6 fold the cells
with TSB (negative control). The fraction N50 kDa showed a
median of 281.58 pg/ml, which was almost 9 times more than
the negative control (TSB). The CS with polymyxin B showed
a median of 136 pg/ml, which was almost 8 times more
than the negative control with polymyxin B. The IL-8 concen-
tration following stimulation with CS showed a median of
3795.65 pg/ml, which was almost 6 times more than the nega-
tive control (TSB). The fraction N50 kDa showed a median of
3739.85 pg/ml, which was 5 times more than the negative con-
trol (TSB). Culture supernatants with polymyxin B showed a
median of 3897.5 pg/ml, which was almost 6 times more com-
pared to the negative control with polymyxin B (Fig. 4). The
TSB medium did not influence the release of IL-6 and IL-
8 compared to the control cell.
4. Discussion
The increase in A. xylosoxidans in the sputum cultures of CF
patients is not accompanied by published data on the virulence
factors of this bacterium. In this study, we provide evidence
that some virulence factors produced by this bacterium may
contribute to pathogenesis in the lungs of CF patients.
Culture supernatants of all A. xylosoxidans isolates caused a
rounding of NCI-H292 cells by 48 h, which presented mem-
brane alterations followed by detachment. The cells treated
with the culture supernatant were also stained with toluidine
blue and hematoxylin and eosin dyes, which showed that the
cells suffered an increase in their normal volumes, the loss of
cellular contacts and the presence of cells with pyknotic nuclei,
which probably signal cell death. Kim et al. [20] investigated
the ability of other opportunistic pathogen of CF, Burkholderia
cenocepacia, to alter the permeability of the respiratory epithe-
lium, but the bacteria did not invade the cell and that in some
way promote the loss of cell junctions, but had not been
shown, however in our study A. xylosoxidans neither invaded
the cell NCI-H292 (data not shown), but the supernatants of
these bacteria resulted in the loss of cell junctions, justifying
the presence of a cytotoxic factor. This cytotoxic factor can
lead to damage in target cells, contributing to the worsening
of the disease that could explain cases such as those studied
by Romano et al. [21], which show rapid lung function decline
after acquiring a chronic A. xylosoxidans infection, leading to
death in less than 5 years.
To estimate the molecular weight of the A. xylosoxidans cy-
totoxin that likely induces the release of interleukins in NCI-
H292 lung cells, the culture supernatant of the bacterium was
subjected to ultrafiltration using XM 300 and XM 50 mem-
branes successively. We observed that the cytotoxic activity
factor was between 50 kDa and 300 kDa, and moreover, it is
a heat-stable cytotoxin. The fraction greater than 50 kDa wasassociated with the highest concentrations of IL-6 and IL-8 re-
lease in NCI-H292 cells. Although the cytotoxin is not yet pu-
rified, these two effects suggest that the cytotoxic factor in the
cells is the same factor that induces the release of interleukins.
Our results are similar to those described by Palfreyman et
al. [15] in bacterial supernatants of some strains of B. cepacia,
which, after boiling, showed little or no reduction in the induc-
tion of IL-8 release in A549 (human lung epithelial adenocarci-
noma) cells. However, we found that the cytotoxic fraction of
all of the A. xylosoxidans samples analysed were thermostable.
Massion et al. [22] revealed that P. aeruginosa supernatant also
induced IL-8 production after heating, using primary bronchial
epithelial cells, a human bronchial epithelial cell line (16-HBE
cells) and monocytes. In their study, the fraction that stimulated
the release of interleukin was approximately 1 kDa, which
310 R.P. Mantovani et al. / Journal of Cystic Fibrosis 11 (2012) 305–311suggested that the activity product was not a protein, differing
from the data obtained for the cytotoxic factor of A. xylosoxi-
dans in our work.
Conversely, Bonfield et al. [23] and Palfreyman et al. [15]
observed an increase in the release of IL-6 and IL-8 in the spu-
tum of CF patients infected with P. aeruginosa and B. cepacia
as further amplification of the inflammatory responses in the
lungs of CF patients was observed. Hansen et al. [9] analysed
the inflammatory responses induced by A. xylosoxidans infec-
tions and observed higher concentrations of IL-6 (39.2 pg /ml)
in the serum of chronically infected patients compared to non-
infected patients and healthy controls, not specifying whether
this interleukin release was due to bacteria or deliverable by it.
However, in our study, the levels of IL-6 produced by the
NCI-H292 cells due to the action of the culture supernatant
fraction N50 kDa were up to 281 pg/ml, which is more than
the IL-6 found in the serum of patients in the study by Hansen
et al. [9]. Our results indicate the action of a cytotoxic factor of
A. xylosoxidans, elucidating its ability to induce the release of
high levels of IL-6 and IL-8 in human lung cells, which leads
to an exacerbated inflammatory response because these cytokines
are potent lymphocytes and neutrophil chemo-attractants that
stimulate the influx of massive numbers of neutrophils into the
airways [10]. These neutrophils are the primary effector cells re-
sponsible for the pathological manifestations of CF lung disease
[4,10]. Inflammation is a vital process needed to counteract infec-
tion, but it is increasingly thought that the normal inflammatory
process is disrupted in CF early in the course of the disease [24].
A study by Hutchison et al. [13] quantified the inflammatory
potency of lipopolysaccharides (LPSs) from eight species of
Gram-negative organisms, among them A. xylosoxidans, and
demonstrated that the LPS of A. xylosoxidans also expressed
these proinflammatory cytokines (IL-6, IL-8 and TNF). Be-
cause LPSs are heat stable and have molecular weights between
10 kDa and 118 kDa [25,26], we assessed whether the cytotoxic
activity produced byA. xylosoxidans could be attributed to the ac-
tion of LPSs. The action of polymyxin-B did not inhibit the cyto-
toxic activity of the bacterial culture supernatant, no cell changes
were observed and the release of interleukins did not decrease
compared with the positive control. Our results suggested that
this cytotoxin is not an endotoxin.5. Conclusion
In conclusion, we observed that the bacterial culture superna-
tant contains a cytotoxic factor able to induce lung cell alterations,
such as vacuoles in the cytoplasm and cell death (chromatin con-
densation and pyknotic nuclei). The main effect of this cytotoxic
factor was the stimulation of proinflammatory cytokine release
(IL-6 and IL-8), which is involved in the inflammatory processes
observed in CF patients and attracts a large number of neutrophils,
which cannot be cleared from the lungs because of the physical
and chemical changes of the mucus, leading to airway obstruction
and tissue damage [20] and worsening the CF disease. Currently,
we are working towards purifying and characterising this toxin for
future descriptions of molecular mechanisms in action.Acknowledgements
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